Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Do "placebo responders" exist?

Kaptchuk TJ, Kelley JM, Deykin A, Wayne PM, Lasagna LC, Epstein IO, Kirsch I, Wechsler ME.

Contemp Clin Trials. 2008 Jul;29(4):587-95. doi: 10.1016/j.cct.2008.02.002. Epub 2008 Feb 23. Review.

PMID:
18378192
2.

ECNP consensus meeting. Bipolar depression. Nice, March 2007.

Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.

Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Review.

PMID:
18501566
3.

Do medical devices have enhanced placebo effects?

Kaptchuk TJ, Goldman P, Stone DA, Stason WB.

J Clin Epidemiol. 2000 Aug;53(8):786-92. Review.

PMID:
10942860
4.

Inhaled corticosteroids in children with persistent asthma: effects on growth.

Zhang L, Prietsch SO, Ducharme FM.

Evid Based Child Health. 2014 Dec;9(4):829-930. doi: 10.1002/ebch.1988.

PMID:
25504972
5.

The placebo response in clinical trials: more questions than answers.

Enck P, Klosterhalfen S, Weimer K, Horing B, Zipfel S.

Philos Trans R Soc Lond B Biol Sci. 2011 Jun 27;366(1572):1889-95. doi: 10.1098/rstb.2010.0384. Review.

6.

Placebo response in asthma: a robust and objective phenomenon.

Kemeny ME, Rosenwasser LJ, Panettieri RA, Rose RM, Berg-Smith SM, Kline JN.

J Allergy Clin Immunol. 2007 Jun;119(6):1375-81. Epub 2007 Apr 23.

PMID:
17451796
8.

Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain.

Dworkin RH, Katz J, Gitlin MJ.

Neurology. 2005 Dec 29;65(12 Suppl 4):S7-19. Review.

PMID:
16385107
9.

Lessons to be learned from placebo arms in psychopharmacology trials.

Doering BK, Rief W, Petrie KJ.

Handb Exp Pharmacol. 2014;225:273-90. doi: 10.1007/978-3-662-44519-8_15.

PMID:
25304537
10.

Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis.

Meissner K, Fässler M, Rücker G, Kleijnen J, Hróbjartsson A, Schneider A, Antes G, Linde K.

JAMA Intern Med. 2013 Nov 25;173(21):1941-51. doi: 10.1001/jamainternmed.2013.10391. Review.

PMID:
24126676
11.

Regulation with placebo effects.

Malani A.

Duke Law J. 2008 Dec;58(3):411-72..

PMID:
19353835
13.

Increasing trial efficiency by early reallocation of placebo nonresponders in sequential parallel comparison designs: application to antidepressant trials.

Boessen R, Knol MJ, Groenwold RH, Grobbee DE, Roes KC.

Clin Trials. 2012 Oct;9(5):578-87. doi: 10.1177/1740774512456454.

PMID:
23060319
14.

[Roaming through methodology. XVII. The placebo effect].

de Craen AJ.

Ned Tijdschr Geneeskd. 2000 Feb 12;144(7):322-4. Review. Dutch.

PMID:
10707743
15.

[Ethical controversies on the use of placebo as control treatment in clinical trials in neurology].

Lahuerta J, Gutiérrez Rivas E, Frías J, Gracia D, Dal-Ré R.

Neurologia. 2007 Mar;22(2):106-13. Review. Spanish.

PMID:
17323236
16.

Evaluation of performance of some enrichment designs dealing with high placebo response in psychiatric clinical trials.

Chen YF, Yang Y, Hung HM, Wang SJ.

Contemp Clin Trials. 2011 Jul;32(4):592-604. doi: 10.1016/j.cct.2011.04.006. Epub 2011 Apr 20.

PMID:
21540126
17.

[Placebos in clinic and research: experimental findings and theoretical concepts].

Klosterhalfen S, Enck P.

Psychother Psychosom Med Psychol. 2005 Sep-Oct;55(9-10):433-41. Review. German.

PMID:
16136447
18.

[Controlled randomized clinical trials].

Jaillon P.

Bull Acad Natl Med. 2007 Apr-May;191(4-5):739-56; discussion 756-8. French.

PMID:
18225427
19.

Placebo controls: historical, methodological and general aspects.

Walach H.

Philos Trans R Soc Lond B Biol Sci. 2011 Jun 27;366(1572):1870-8. doi: 10.1098/rstb.2010.0401. Review.

20.

The use of placebo in clinical trials on bipolar disorder: a new approach for an old debate.

Vieta E, Carné X.

Psychother Psychosom. 2005;74(1):10-6.

PMID:
15627851

Supplemental Content

Support Center